These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 8636275

  • 1. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 2. Source localization of androgen excess in adolescent girls.
    Ibáñez L, Potau N, Zampolli M, Prat N, Gussinyé M, Saenger P, Vicens-Calvet E, Carrascosa A.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
    [Abstract] [Full Text] [Related]

  • 3. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL, Barnes RB, Ehrmann DA.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [Abstract] [Full Text] [Related]

  • 4. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 5. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.
    Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1599-603. PubMed ID: 8501168
    [Abstract] [Full Text] [Related]

  • 6. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
    Azziz R, Bradley EL, Potter HD, Boots LR.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
    [Abstract] [Full Text] [Related]

  • 7. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing.
    Ibáñez L, Potau N, Zampolli M, Street ME, Carrascosa A.
    Fertil Steril; 1997 May; 67(5):849-55. PubMed ID: 9130889
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
    Ibáñez L, Potau N, Marcos MV, de Zegher F.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
    [Abstract] [Full Text] [Related]

  • 9. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B, Re T, Passini E, Bochicchio D, Ferrario R.
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [Abstract] [Full Text] [Related]

  • 10. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [Abstract] [Full Text] [Related]

  • 11. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V, Balducci R, Bianchi P, Mangiantini A, Sciarra F.
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [Abstract] [Full Text] [Related]

  • 12. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM, MacLachlan V, Montalto J, Calderon I, Healy DL, McLachlan RI.
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 14. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 15. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [Abstract] [Full Text] [Related]

  • 16. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [Abstract] [Full Text] [Related]

  • 17. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I, Audí Parera L, Granada Ybern ML, Lucas Martín A, Pizarro Lozano E, Foz Sala M, Sanmartí Sala A.
    Med Clin (Barc); 1998 Feb 14; 110(5):171-6. PubMed ID: 9547720
    [Abstract] [Full Text] [Related]

  • 18. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D, Leigh A, Wilson C, Donaldson A, Franks S.
    Clin Endocrinol (Oxf); 1995 May 14; 42(5):475-81. PubMed ID: 7621565
    [Abstract] [Full Text] [Related]

  • 19. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr 14; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
    Benjamin F, Deutsch S, Saperstein H, Seltzer VL.
    Fertil Steril; 1986 Aug 14; 46(2):215-21. PubMed ID: 3015693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.